Nanotechnology for Drug Delivery: Global Market for Nanocarriers


February 7, 2012
129 Pages - SKU: CMPC3810206
License type:
TABLE OF EXHIBITS
EXECUTIVE SUMMARY
CHAPTER 1 - INTRODUCTION
REPORT SCOPE
METHODOLOGY
Procurement
Calculation of CAGR
THE NANOSCALE
Two biological examples that illustrate nanoscale:
CHAPTER 2 – NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
OVERVIEW OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
Why is Nanotechnology A Critical Application for Medicine and Biomedicine?
Why Nanotechnology Is Needed for Medicine and Biomedicine
WHAT ARE THE KEY DRIVERS FOR ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE?
The Aim Of Drug Targeting
Rapid Market Growth
Market Drivers For Enhanced Drug Delivery
Increasing Proportion of The Ageing Population
Demand For More Affordable Health Care
Public Health – Ending disease
Demand for More Innovation
Social responsibility
THE KEY APPLICATIONS OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
How Nanotechnology Can Benefit Drug Delivery
Nanotechnology in Medical and Biomedical Diagnostics
Nanotechnology in Regenerative Medicine and Tissue Engineering
Other Applications For Nanomaterials In The Medical And Pharmaceutical Sector
PROMISING EXAMPLES OF NANOTECHNOLOGY ENABLED DRUG DELIVERY
Case Study 1 – Magnetic Field Acts as "Remote Control" to Deliver Nanomedicine
Case Study 2 - Adaptive Micro and Nanoparticles: Temporal Control Over Carrier
Properties to Facilitate Drug Delivery
Case Study 3 – Fabrication of a Nanocarrier System Through Self-Assembly of Plasma
Protein And Its Tumour Targeting
Case Study 4 – IBM And The Institute of Bioengineering And Nanotechnology Find
Breakthrough For MRSA
CHAPTER 3 – RISK & REGULATION
THREE KEY BARRIERS TO THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
Nanotoxicity Nanopollution and Nanosafety
Ethical Considerations Of Nanotherapies
Delayed Nanoregulation
Nanotechnology for Drug Delivery:
Global Market for NanoCarriers
FIVE CURRENT & FUTURE CHALLENGES IN THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
Current & Future Challenges of Nanosafety And Risk Management
Current & Future Challenges of Nanoregulation
Current & Future Challenges for the Nanomedicine Industry
Current & Future Challenges of Sustained Innovation
Current & Future Challenges of Cooperation
CHAPTER 4 – MARKET FOR NANOCARRIERS
GLOBAL MARKET ANALYSIS: 2000-2010 (WITHOUT SEGMENTATION)
GLOBAL MARKET FORECAST: 2011-2021 (WITHOUT SEGMENTATION)
DISCUSSION OF NANOPARTICLES & NANOCARRIERS
Overview of The Key Nanotechnologies Used in Drug Delivery Sorted by Applications
Nanopharmaceuticals
Nanotechnology In Drug Delivery
Nanobiotechnology In Drug Delivery
Analytical Techniques For Nanoparticle Drug Delivery
Properties
Production of Nanoparticles
Measuring Dispersion of Nanoparticles
Characterisation of Carrier Systems
Nanocarriers
Classification of Nanocarriers
Multifunctional Nanocarriers - Drug Delivery And Medical / Biomedical Diagnostics
Nanocarriers as Drug Carriers
What Can Nanoparticles do in Drug Delivery?
Polymer-Based Nanocarriers (Polymeric Nanoparticles)
Lipid-Based Nanocarriers
Organic Nanocarriers
Inorganic Nanocarriers
Disadvantages Associated With Nanocarriers
The Most Relevant Technologies in The Key Area of Nanotechnology in Drug Delivery
Stage of Development of Key Nanotechnologies Used in Drug Delivery
Clinically Approved Nanocarrier-Based Drug Formulations With Presence on The Market
The First Nanoparticle Drug Delivery System Reaches The Market
Present And Future Applications
TECHNOLOGY ADOPTION ROADMAP
Projected Product Pipeline For Nanocarrier-Based Drug Formulations In Drug Delivery
Market
Available Applications Of Nanoparticles In Drug Delivery
Semapimod® (cytokine, pharmasciences)
Paxceed™
Theralux™
Nucryst®
iSPERSE™
ANALYSIS OF TAM FOR NANOCARRIERS: 2000-2010
TAM FORECAST FOR NANOCARRIERS: 2011-2021
APPENDIX
PUBLISHING ACT